Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04837196
Title Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Astellas Pharma Global Development, Inc.


Advanced Solid Tumor

ovarian cancer

colorectal cancer


ASP7517 + Pembrolizumab


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Recruiting Atlanta Georgia 30322 United States Details
University of Chicago Recruiting Chicago Illinois 60603 United States Details
University of Iowa Hospitals Recruiting Iowa City Iowa 52242 United States Details
UPCI Hillman Cancer Center Recruiting Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from for the field